SCHEMBL27280249

SCHEMBL27280249

CN1CCNC(C(F)(F)F)CC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944710 0.81 LATS1 (0.32)
SCHEMBL2740577 0.81 LATS1 (0.32)
SCHEMBL31235500 0.74
SCHEMBL17673530 0.74
Hydrochloric Acid SCHEMBL21957165 0.71
SCHEMBL7936305 0.71 PNMT (0.32)
SCHEMBL12329935 0.70
SCHEMBL25861671 0.70
SCHEMBL19866287 0.70
SCHEMBL232815 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081447-A1 EGFR INHIBITORS FOR TREATING LUNG CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-04-18 WO disclosed